Complete Remissions with Brentuximab Vedotin (SGN-35) in Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma Shustov, A. R., Advani, R., Brice, P., Bartlett, N. L., Rosenblatt, J. D., Illidge, T., Matous, J., Ramachandren, R., Fanale, M. A., Connors, J. M., Yang, Y., Sievers, E. L., Kennedy, D. A., Pro, B. AMER SOC HEMATOLOGY. 2010: 423–24

View details for Web of Science ID 000289662201064